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Abstract
Background: Polycyclic aromatic hydrocarbons
(PAHs), such as benzo[a]pyrene (B[a]P), are ubi-
quitous toxic environmental pollutants capable of
inducing cell death. Intracellular pH plays a key role
in the regulation of cell survival and death. Our
previous works have demonstrated that intracellular
alkalinization mediated by Na+/H+ exchanger 1
(NHE-1) is a critical event involved in B[a]P-induced
apoptosis. The aim of this study was to further
elucidate the mechanisms of NHE-1 activation upon
B[a]P exposure. Methods: We tested the effects of
plasma membrane cholesterol enrichment or
depletion on B[a]P-induced NHE-1 activation related
to apoptosis. We isolated cholesterol-rich plasma
membrane microdomains to assess NHE-1 sub-
membrane location and immunoprecipitated NHE-1
from the different sub-membrane fractions obtained
to examine NHE-1 protein interactions during B[a]P-
induced apoptosis. Results: We found that NHE-1 is
preferentially located in cholesterol-rich micro-
domains and that B[a]P activates NHE-1 via its
relocation and binding of calmodulin outside these
specialized plasma membrane microstructures; these
events are necessary for the execution of the
apoptosis-related intracellular alkalinization.
Conclusion: Plasma membrane location of NHE-1
affects its protein interactions and apoptotic function.
Introduction
Intracellular pH (pHi) is a highly regulated cellular
parameter, whose perturbations by transporters or by
metabolic changes can induce proliferative or apoptotic
signals [1-4]. pHi has been recognized to be a promising
target for cancer therapy or for prevention against
chemical-induced toxicity [5, 6]. Polycyclic aromatic
hydrocarbons (PAHs) such as benzo[a]pyrene (B[a]P)
constitute a major class of widely distributed
environmental contaminants [7, 8]. In our previous works,
we found that intracellular pH homeostasis was involved
in B[a]P-induced apoptosis [9].
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The ubiquitous Na+/H+ exchanger isoform 1
(NHE-1) plays an essential role in intracellular pH
regulation and affects numerous cell signaling pathways
[10-12]. Alteration of NHE-1 activity can lead to cell
dysfunction, which may ultimately lead to the development
of pathologies. For instance, NHE-1 activity has been
related to ischaemia/reperfusion [13], cardiac hypertrophy
[14], fibrosis [15] and cancer [16]. NHE-1 also regulates
cell death upon diverse stimuli [2, 9, 17]. We have
previously demonstrated that B[a]P activates NHE-1; the
related H+ efflux leads to an early and transient,
intracellular alkalinization involved in apoptosis [9, 18].
Plasma membrane constitutes the first cellular
barrier that chemical agents encounter. According to
hydrophobicity size and charge, xenobiotics can perturb
membrane properties, and affect transmembrane proteins
like channels, enzymes and transporters [19]. Plasma
membrane is characterized by its microstructure, more
particularly by the presence of cholesterol-rich
microdomains (CRM) [20]. Cholesterol-rich microdo-
mains also called lipid rafts have been implicated in the
regulation of ion channels and transporters such as
NHE-3 [21, 22]. Regarding NHE-1, it is only recently
that plasma membrane modifications have been shown
to modify its activity [23]. Recent studies have described
NHE-1 as preferentially located in cholesterol-rich
microdomains [11, 12, 24]; their destabilization can alter
its membrane micro-distribution and activity [25].
In the present study, we have explored the eventual
involvement of cholesterol-rich microdomains in
B[a]P-induced NHE-1-apoptotic activity. We found that
B[a]P activated NHE-1 via its relocation outside
cholesterol-rich plasma membrane microdomains where
it can interact with calmodulin.
Materials and Methods
Chemicals
If not otherwise stated chemicals were from Sigma
Chemicals Co (St Louis, MO, USA). Cholesterol oxidase
(CholOx) was purchased from Calbiochem (France Biochem,
Meudon, France). Hoechst 33342 was purchased from
Molecular Probes (Invitrogen, Cergy Pontoise, France). Mouse
monoclonal anti-caveolin-1, mouse monoclonal anti-flotillin-1
and mouse monoclonal anti-NHE-1 were purchased from
Becton Dickinson (BD Biosciences, San Jose, CA). Rabbit
polyclonal anti-p53-phospho Serine 15, goat polyclonal anti-
CD71 and polyclonal rabbit anti-NHE-1 were purchased from
Santa Cruz Biotechnology (Tebu-bio SA, Le Perray en Yvelynes,
France). Secondary antibody conjugated to horseradish
peroxidase was from Dako A/S (Glostrup, Denmark).
F258 cell culture and apoptosis measurement
F258 rat liver epithelial cell line was cultured in Williams’
E medium supplemented with 10% fetal calf serum, 2 mM
L-glutamine, 5 IU/ml penicillin, and 0.5 mg/ml streptomycin at
37°C under a 5% CO2 atmosphere, treated 24 h following seeding
as previously described [9, 26]. Microscopical detection of
apoptosis was performed in both floating and adherent cells,
using Hoechst 33342 labeling. Caspase-mediated cleavage of
DEVD-AMC was measured by spectrofluorimetry (Spectramax
Gemini plate reader, Molecular Devices, Sunnyvale, CA) at the
excitation/emission wavelength 380/440 nm.
Measurement of pHi and equivalent acidic efflux
The pHi of F258 cells was monitored using the pH-
sensitive fluorescent probe, carboxy-SNARF-1-AM (carboxy-
seminaphtorhodafluor-acetoxymethylester; Molecular Probes)
as previously described [9]. The emission ratio 640/590 nm
(corrected for background fluorescence) detected from
intracellular SNARF was calculated and converted to a linear
pH scale using an in situ calibration obtained by the nigericin
technique. Sarcolemmal acid equivalent efflux was estimated
using the ammonium pre-pulse method and the following
equation: JeH =βi x dpHi/dt, where βi is the intrinsic intracellular
buffering power and dpHi/dt is the rate of pHi recovery at any
given pHi as previously described [9].
Western blotting immunoassays
After treatment, cells (both floating and adherent) were
harvested, centrifuged, washed with PBS, and lysed for 10 min
on ice in Cytobuster lysis buffer (Invitrogen, Paisley, UK). DNA
and cell debris were removed by centrifugation at 13000 rpm
for 5 min at 4°C. Western blot analysis was performed as
previously described [27]. Equal loading was checked by
Ponceau technique and β-actin immunoblotting.
Immunoprecipitation
F258 cells were washed with ice-cold PBS and preparation
of membrane protein extracts was carried out as previously
described [28]. Solubilized membranes were incubated
overnight at 4°C with different anti-NHE-1 antibodies or rabbit
polyclonal anti-calmodulin antibody or IgG negative control
antibody. Immune complexes were mixed with protein G
magnetic beads (New England Biolabs, Ipswich) for 2 h at 4°C,
washed three times with ice-cold lysis buffer, and separated
using a magnetic separation rack (New England Biolabs). The
immune complexes were dissociated by adding Laemmli buffer
and heating for 5 min at 70°C. Proteins were resolved on
SDS-PAGE analyzed by western immunoblotting using anti-
NHE-1 antibodies or rabbit polyclonal calmodulin antibody.
Cholesterol-rich microdomain isolation
F258 cells (2 x 108) were washed with ice-cold PBS and
scraped in 3 ml of PBS. After two washes, pellets were lysed in
1 ml MBS-buffered saline solution as previously described [25].
Lysates were then diluted with 2 ml MBS buffer containing
80% sucrose (w/v) and placed at the bottom of a linear sucrose
gradient consisting of 8 ml 5–40% sucrose (w/v) in MBS.
Samples were centrifuged at 39000 rpm for 20 h at 4°C, and
Tekpli/Huc/Sergent/Dendelé/Dimanche-Boitrel/Holme/Lagadic-
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eleven fractions of 1 ml each were collected from the top of the
gradient. Proteins were dosed according to the Lowry method
(Biorad, Marnes la Coquette, France). The eleven fractions were
then characterized according to their cholesterol content and
their enrichment in caveolin-1 and flotillin-1 [29].
Cholesterol analysis
Lipids were extracted as previously described [25]. The
chloroformic phase was evaporated with argon; 100 µl of
ethanol was added and the amount of cholesterol in 60 µl of
ethanol was determined with a colorimetric dosage. The samples
were thus incubated with 200 µl of infinity cholesterol liquid
reagent (ThermoTrace, Melbourne-Australie). The absorbance
was measured at 492 nm on an ELISA plate reader. Cholesterol
content was expressed in µM / µg proteins.
Statistical analysis
All data are quoted as mean ± standard error of mean.
ANOVA followed by a Student-Newman-Keuls post-test was
used to compare means. In case of non-normal distributions,
ANOVA followed by Dunn post-test was used to compare
medians. p < 0.05 was considered statistically significant. All
results are from at least three independent experiments. * or #
p< 0.05, ** p< 0.01, *** p< 0.001.
Results
NHE-1 is relocated outside cholesterol-rich
microdomains (CRM) upon B[a]P treatment
B[a]P has been found to induce a plasma membrane
remodeling [29, 30]. Besides, NHE-1 has been described
to be sensitive to changes in membrane microstructure
[23, 25]. In the present study, we investigated whether
B[a]P-induced membrane remodeling affected NHE-1
sub-membrane location and activity.
Mechanisms of Apoptotic Activation of NHE-1
Fig. 1. B[a]P alters the plasma membrane
location of NHE-1: F258 cells were pre-
treated or not 1 h with Chol (30 µg/ml) or
MCD (2 mM), after which 50 nM B[a]P
was added for a further 48 h. Cholesterol-
rich microdomains were then isolated.
Western blots are representative from at
least three independent experiments. A:
Western blotting analysis of Caveolin-1
(Cav-1), Flotilin-1 (Flot-1) and transferrin
receptor (CD71) in the 11 isolated
fractions. This analysis shows that
fractions (1-7) correspond to cholesterol-
rich microdomains (CRM), while fractions
(8-11) correspond to the soluble fractions
(S). B: Western blot analysis of NHE-1
distribution in the 11 isolated fractions.
C: Western blot analysis of  NHE-1,
Cav-1, Flot-1 and CD71 distribution in
cholesterol-rich microdomains (CRM)
and soluble (S) fractions. Cav-1 and
Flot-1 or CD71 serve as loading controls
of CRM or S fractions, respectively, since
they are markers of these fractions. D:
NHE-1 cellular location is seen in red,
Caveolin-1 location is seen in green,
nuclei are seen in blue in fluorescence
microscopy (magnification 400 x). Co-
locations of NHE-1 and caveolin-1 are
seen in orange. The experiments were
repeated at least five times, with similar
results.
Cell Physiol Biochem 2012;29:657-666
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F258 cells were lysed in 1% Triton X-100 buffer at
4°C and fractionated on a sucrose gradient to obtain
detergent-resistant-membrane i.e cholesterol-rich
microdomains (CRM; fractions 1 to 7), and soluble
Tekpli/Huc/Sergent/Dendelé/Dimanche-Boitrel/Holme/Lagadic-
Gossmann
Fig. 3. F258 cells were pre-treated or not for 1 h with
MCD, Chol, CholOx, Thio (thiourea) or W7, and
subsequently co-treated or not with 50 nM B[a]P
during 48 h. A: 60 µg of whole cell lysate were
separated on 10% SDS polyacrylamide gel
electrophoresis. Immunoblot was probed with rabbit
polyclonal anti-p53, and rabbit polyclonal anti-
phospho-p53 (Ser 15). B: H2O2 production was
analyzed using H2DCF-DA probe and flow cytometry.
A 20 min-treatment with H2O2 was used as positive
control, and Thio was used as an antioxidant molecule.
Peaks are representative of three independent
experiments.
Fig. 2. Plasma membrane is involved in B[a]P-
induced apoptosis: F258 cells were pre-treated 1 h
with MCD (2 mM), CholOx (0.01 UI/ml) or Chol (30
µg/ml) and subsequently treated or not with 50 nM
B[a]P during 48 h for pHi and NHE-1 activity analysis,
or for 72 h for cell death determination. A: Apoptotic
nuclei were analyzed by Hoechst 33342 staining. n=5
independent experiments. White bars: vehicle, black
bars: B[a]P. ***: p<0.001, vehicle versus B[a]P; *;
p<0.05, inhibitor versus inhibitor+B[a]P; #: p<0.05,
B[a]P versus inhibitor+B[a]P. B: DEVDase (caspase)
activities were measured by spectrofluorimetry,
averaged from at least five independent experiments,
and expressed as RFU (relative fluorescence unit) /
µg proteins normalized by the RFU of control cells.
**: p<0.01, vehicle or inhibitor versus B[a]P or
inhibitor+B[a]P; #: p<0.05, B[a]P versus
inhibitor+B[a]P. C and D: Resting pHi values were
monitored by microspectrofluorimetry using the pH-
sensitive probe, carboxy-SNARF-1-AM. pHi values
were derived from a pHi calibration curve, n=9
independent experiments. **: p<0.01, significant
B[a]P-induced intracellular alkalinization compared
to B[a]P-untreated cells, #: p<0.05, B[a]P versus
inhibitor+B[a]P. E: pHi recovery rate was monitored
following an acid load induced upon removal of
NH4Cl from extracellular medium. Acidic efflux was
calculated from at least nine independent experiments,
at pHi=6.85. White bars: vehicle, black bars: B[a]P. *:
p<0.05, vehicle versus B[a]P; #: p<0.05, vehicle versus
inhibitor.
Cell Physiol Biochem 2012;29:657-666
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fractions (S, fractions 8 to 11); see Fig. 1A for fraction
characterization. Western blotting analyses showed that
in control cells, NHE-1 was preferentially located in
cholesterol-rich microdomains enriched in caveolin-1 and
flotillin-1 (Fig. 1B, 1C). Immunofluorescence experiments
also showed that in control cells NHE-1 co-localized with
caveolin-1 (Fig. 1D). Interestingly, B[a]P exposure led to
NHE-1 relocation outside CRM, as shown by the increase
of NHE-1 concentration in S fractions concomitant with
a decrease in CRM fractions (Fig. 1B, 1C); a loss of co-
location between NHE-1 and Cav-1 was also visualized
(Fig. 1D). Cholesterol enrichment of cellular membranes
(Chol, 30 µg/mL) prevented from B[a]P-induced
relocation of NHE-1 (Fig. 1C, 1D). Cholesterol depletion
of the plasma membrane using methyl-β-cyclodextrin
(MCD, 2 mM) induced a relocation of NHE-1 outside
cholesterol-rich microdomains (Fig. 1C).
These results therefore indicated that B[a]P triggered
NHE-1 relocation from CRM to soluble fractions, such a
relocation being inhibited by cholesterol enrichment of
plasma membrane.
NHE-1 sub-membrane location is associated with
the apoptosis-related intracellular alkalinization
We previously showed that B[a]P-induced NHE-1
activation was involved in the related apoptosis [9]. To
determine whether B[a]P-induced relocation of NHE-1
outside cholesterol-rich microdomains was related to its
apoptotic activation, we tested the effects of plasma
membrane cholesterol enrichment (Chol) or depletion
(methyl-β-cyclodextrin [MCD, 2mM]; cholesterol oxidase
[CholOx, 0.01 U/mL]) on NHE-1 activation related to
B[a]P-induced apoptosis.
The counting of cells with apoptotic nuclei and the
analysis of caspase 3/7 activity showed that Chol, MCD
or CholOx all inhibited B[a]P-related apoptosis (Fig. 2A,
2B). After 48 h of exposure to B[a]P (50 nM), we detected
an intracellular alkalinization due to NHE-1 activation;
MCD, CholOx and Chol all inhibited B[a]P-induced
intracellular alkalinization (Fig. 2C, 2D). All compounds
also inhibited B[a]P-induced H+ efflux due to NHE-1
activation (Fig. 2E). Note also that MCD or CholOx alone
induced both an intracellular alkalinization (Fig. 2D), and
an increase in NHE-1-related H+ efflux (Fig. 2E). MCD
or Chol did not inhibit B[a]P-induced p53 Ser-15
phosphorylation, or H2O2 production two other main
B[a]P-induced apoptotic events (Fig. 3A, 3B); thus, we
concluded that the inhibition of B[a]P-induced apoptosis
by cholesterol enrichment or depletion involved a
modulation of NHE-1 activity.
Mechanisms of Apoptotic Activation of NHE-1
Fig. 4. Calmodulin is involved in B[a]P-induced apoptosis:
F258 cells were pre-treated or not for 1 h with calmodulin
antagonist (W7 25 or 50 µM) and subsequently co-treated or
not with 50 nM B[a]P during 72 h for cell death analysis. A:
Caspase activities were measured by spectrofluorimetry,
averaged from five independent experiments, and expressed as
RFU/µg proteins normalized by the RFU of control cells. ***:
p<0.001, vehicle versus B[a]P; #: p<0.05, B[a]P versus
inhibitor+B[a]P. B: Apoptotic nuclei were analyzed by Hoechst
33342 staining. n=5 independent experiments. White bars:
vehicle, black bars: B[a]P. ***, **, *: p<0.001, p<0.01, p<0.05,
respectively, vehicle or inhibitor versus B[a]P or inhibitor+B[a]P;
#: p<0.05, B[a]P versus inhibitor+B[a]P. C and D: Resting pHi
measurements were monitored by microspectrofluorimetry using
the pH-sensitive probe, carboxy-SNARF-1-AM (eleven
independent experiments). **: p<0.01, significant B[a]P-
induced intracellular alkalinization compared to B[a]P-untreated
cells; ***: p<0.001, vehicle versus B[a]P; #: p<0.05, B[a]P versus
inhibitor+B[a]P. E: pHi recovery rate was monitored following
an acid load induced upon removal of NH4Cl (20 mM) from
extracellular medium. Acidic efflux was calculated from seven
independent experiments, at pHi=6.7. *: p<0.05, vehicle versus
B[a]P; #: p<0.05, vehicle versus inhibitor. F: 60 µg of whole cell
lysate were separated on 10% SDS polyacrylamide gel
electrophoresis. Immunoblot was probed with rabbit polyclonal
anti-p53, and rabbit polyclonal anti-phospho-p53 (Ser 15).
Cell Physiol Biochem 2012;29:657-666
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Fig. 5. Calmodulin binds to NHE-1
outside cholesterol-rich micro-
domains: F258 cells were treated or not
with 50 nM B[a]P during 48 h. A:
Immunoprecipitation of NHE-1 from
plasma membrane protein extracts and
subsequent immunobloting of CaM.
B: Immunoprecipitation of NHE-1 or
CaM from CRM or detergent-soluble
membrane fractions. Two different
NHE-1 antibodies were used.
Interaction between the proteins was
checked by immunoblotting. As
control for the immunoprecipitation
experiments a negative control
antibody was used (IgG); we showed
by blotting the heavy chain of
antibodies used in immunopreci-
pitation that the same amount of
antibody was loaded.
Tekpli/Huc/Sergent/Dendelé/Dimanche-Boitrel/Holme/Lagadic-
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Involvement of calmodulin in B[a]P-induced
apoptosis
NHE-1 contains a regulatory calmodulin-binding site
in its carboxyl-terminal domain; binding of calmodulin to
NHE-1 has been shown to activate the exchanger
[31, 32]. We investigated the possible involvement of
calmodulin (CaM) in B[a]P-induced NHE-1 activation.
Determination of apoptotic nuclei and measurement of
caspase activity showed that the calmodulin antagonist
W7 (25 or 50 µM) decreased apoptosis (Fig. 4A, 4B). In
order to avoid any secondary effect of W7, we decided
to use the lowest concentration in following experiments.
W7 inhibited the B[a]P-induced intracellular alkalinization
(Figs. 4C, 4D), and the NHE-1-related H+ efflux (Fig.
4E), thus indicating a role for calmodulin in B[a]P-induced
NHE-1 activation. W7 did not affect p53 Ser15
phosphorylation (Fig. 4F).
Calmodulin and NHE-1 interact outside
cholesterol-rich microdomains
NHE-1 is an ionic transporter also involved in protein
scaffolding [10]. We made the hypothesis that NHE-1
location in or outside CRM might regulate its interaction
with calmodulin. We first found by immunoprecipitating
NHE-1 from cellular membrane extracts that calmodulin
(CaM) bound NHE-1 when cells were exposed to B[a]P
(Fig. 5A). Moreover, immunoprecipitation of NHE-1 from
soluble or cholesterol-rich microdomains (CRM)
membrane fractions revealed an interaction between
NHE-1 and CaM only in soluble fractions. The
immunoprecipitation of CaM with the detection of
NHE-1 in soluble fractions confirms this interaction
outside CRM. Our data therefore suggested that the
interaction between NHE-1 and CaM was involved in
the exchanger activation, increased when cells were
exposed to B[a]P, and occurred outside the cholesterol-
rich plasma membrane domains (Fig. 5B).
Discussion
NHE-1 can be activated during apoptosis by low
concentrations of B[a]P [9]. The present study aimed at
deciphering the mechanisms of apoptosis-related
NHE-1 activation. Our results show that B[a]P induces
an exit of NHE-1 from cholesterol-rich microdomains
where it interacts with calmodulin; both events are
necessary for B[a]P-induced NHE-1 activation (Fig. 6).
These findings are fundamentally and conceptually
relevant because (1) they confirm in a more physiological
cell model that sub-membrane location of NHE-1 can
affect its activity; (2) they suggest that NHE-1
sub-membrane location may affect its protein-protein
interactions and functions; and (3) they reveal
the implication of CaM in the apoptotic function of
NHE-1.
Cell Physiol Biochem 2012;29:657-666
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Fig. 6. Schematic summary
of B[a]P-induced NHE-1
activation in F258 cells.
CYP1 : cytochrome P450 ;
AhR : aryl hydrocarbon
receptor : CaM : calmo-
dulin.
Mechanisms of Apoptotic Activation of NHE-1
NHE-1 is a prominent pHi-regulator, also involved
in the regulation of cell volume, sodium homeostasis, cell
adherence, cell migration, and in the regulation of the
balance between proliferation, cell survival and apoptosis
(for review, see [33]). Our previous studies showed that
in a cell line over-expressing NHE-1, NHE-1 was
preferentially located in cholesterol-rich microdomains,
and that its intracellular protons cooperative regulation
was modulated by its sub-membrane location [25]. We
found here that, in F258 cells, B[a]P-induced NHE-1
activation was multifactorial; indeed B[a]P-induced
membrane remodeling led to NHE-1 relocation outside
cholesterol-rich microdomains, which allowed the binding
of CaM to NHE-1. Inhibition of NHE-1 relocation outside
CRM using exogenous cholesterol, or inhibition of CaM
activity by W7, both prevented B[a]P-induced apoptosis
and NHE-1 activation.
We also found that cholesterol depletion of CRM
inhibited B[a]P-induced apoptosis. Cholesterol enrichment
or depletion had the same effects on apoptosis, which
could seem contradictory. However, with regard to this
latter point, it is important to note that cholesterol depletion
alone was found to relocate NHE-1 outside CRM ([25]
and Fig. 1C), and to activate NHE-1. Such a pre-activation
of NHE-1 was found to abolish the B[a]P-induced
NHE-1 activation (Fig. 2E), and the related intracellular
alkalinization (Fig. 2C). Thus, cholesterol depletion
activates NHE-1 to a level at which B[a]P cannot elicit
any further effect. In this context, inhibition of
B[a]P-induced NHE-1 activation via cholesterol depletion
appeared to reduce apoptosis. It is interesting to stress
that the B[a]P-related alkalinization and complementary
apoptotic signals, could not be replaced by an intracellular
alkalinization elicited by cholesterol-depleting agents;
actually, it demonstrates that the B[a]P-induced
alkalinization, which has been previously shown to be
transient [9], needs to act with other concomitant
intracellular signals to contribute to apoptosis.
The regulation of transporters or channels activities
by membrane microdomains has been previously reported
Cell Physiol Biochem 2012;29:657-666
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e.g for P-glycoprotein and big-potassium channels
[34-36]. Cholesterol rich microdomains-dependent
regulation of protein complexes has also been well
described in different physiological processes like for the
formation of the death inducing signaling complex (DISC)
[37], or for the epidermal growth factor receptor (EGFR)
signaling [38]. Several ion channels or transporters see
their activity regulated by selective binding of protein or
phosphorylation inside or outside cholesterol rich
microdomains (CRM). It has recently been suggested
that the activation of store operated Ca2+ entry is
dependent on the formation of a protein complex in
cholesterol-rich microdomains [39]. Also, the epithelial
sodium channel (ENaC) activation by SGK1 has been
shown to require intact cholesterol-rich microdomains as
signaling platform [40].
Concerning NHE-1, we confirmed in a more
physiological model, i.e. expressing an endogenous level
of NHE-1, that its location in or out cholesterol-rich
microdomains regulates its activity. Moreover, our data
suggest that NHE-1 ability to interact with other proteins
(interactome) might be modified by its sub-membrane
location. The fact that NHE-1 binds CaM outside CRM
suggests that the plasma membrane sub-location of the
exchanger might represent a putative regulator of NHE-
1 functions as a signaling complex, through controlling its
anchoring and scaffolding properties for signaling proteins
(for review, see [10]). Cholesterol-rich microdomains
might thus regulate NHE-1 function of anchoring for
cytoskeleton [41], or regulate its phosphorylation [11, 17,
42]. Interestingly, NHE-1 has been involved in either cell
survival or cell death pathways [2, 9, 17]. The interaction
of NHE-1 and ERM proteins has been shown to recruit
phosphatidyl-inositol 3-kinase (PI3K) resulting in the
activation of the PKB/Akt survival pathway [43];
moreover, CRM seem to contribute to Akt/PKB plasma
membrane recruitment and activation [44]. In this context,
one might suppose that NHE-1 and Akt interaction would
take place preferentially in CRM to participate in cell
survival. In contrast, here we show that NHE-1 location
outside CRM and its interaction with CaM can trigger
apoptotic signals. NHE-1 sub-location in plasma
membrane would deserve further attention in the
future since it might explain the multifaceted function of
NHE-1 as a trigger of survival or apoptosis.
NHE-1 contains a calmodulin binding region
within its carboxyl-terminal regulatory domain, which
is important for its regulation by fully overlapping its
auto-inhibitory domain [31, 32, 45]. In the context of
the F258 cells exposed to B[a]P, the redistribution of
the exchanger outside cholesterol-rich microdomains is
associated with the binding of calmodulin to NHE-1.
When using the CaM antagonist W7, we found that
this compound fully inhibited B[a]P-induced NHE-1
activation; whereas no significant effects were observed
on NHE-1 activity under control conditions. It has
been demonstrated that the binding of the phosphorylated
form of CaM to NHE-1 could play an important role in
the exchanger up-regulation following bradykinin B2
receptor activation [46], upon exposure to mitogen
[47], EGF [48], or following hypertonic shock [49]. As
our present study shows for the first time that interaction
between NHE-1 and CaM could take place outside
CRM, it would be interesting to test if CaM binds to NHE-
1 inside or outside CRM under the above cited
conditions.
CaM binding to NHE-1 can be Ca2+ dependent
[31, 45]; interestingly, we observed a B[a]P-induced
increase of intracellular Ca2+ in our cell model (data not
shown). Also, a recent study showed the implication of
PKB/Akt kinase in the regulation of NHE-1; indeed
PKB/Akt mediates phosphorylation of NHE-1 on Ser648,
thus leading to an inhibition of the exchanger via inhibition
of binding of CaM [28]. In this context, a
dephosphorylation of PKB/Akt might lead to a decrease
of PKB/Akt activity, thereby favoring CaM binding to
the exchanger.
In conclusion, this study demonstrates that
B[a]P-induced membrane remodeling participates in
NHE-1 activation by inducing its relocation outside CRM,
an event that would favor calmodulin binding to the
exchanger and the execution of the apoptotic cascade.
Xenobiotic-induced early plasma membrane modifications
can thus target NHE-1 and regulate its functions. The
present data might support the idea that NHE-1 activation
inside or outside CRM might be a key factor underlying
the ambivalent role of this transporter in the regulation of
the balance between proliferation, cell cycle arrest, cell
survival and apoptosis.
Abbreviations
B[a]P (benzo[a]pyrene); CaM (calmodulin);
Cav-1 (caveolin-1); CRM (cholesterol-rich
microdomains); Flot-1 (flotillin-1), NHE-1 (Na+/H+
exchanger isoform 1); PAH (polycylic aromatic
hydrocarbon); pHi (intracellular pH).
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